NO20053073L - Pig polymorphisms and methods for proving such. - Google Patents
Pig polymorphisms and methods for proving such.Info
- Publication number
- NO20053073L NO20053073L NO20053073A NO20053073A NO20053073L NO 20053073 L NO20053073 L NO 20053073L NO 20053073 A NO20053073 A NO 20053073A NO 20053073 A NO20053073 A NO 20053073A NO 20053073 L NO20053073 L NO 20053073L
- Authority
- NO
- Norway
- Prior art keywords
- pig
- resistant
- polymorphisms
- proving
- methods
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 102000054765 polymorphisms of proteins Human genes 0.000 title 1
- 241000588724 Escherichia coli Species 0.000 abstract 1
- 241000282887 Suidae Species 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000000688 enterotoxigenic effect Effects 0.000 abstract 1
- 239000000523 sample Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/108—Swine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Identifisering av en gris som motstandsdyktig eller ikke-motstandsdyktig mot enterotoksigen E. Coli. Særlig frembringes det fremgangsmaoter, prober og DNAmolekyler som omfatter identifisering av en gris som motstandsdyktig eller ikkemotstandsdyktig mot ETEC. Det frembringes også fremgangsmaoter for å ale opp gris ved anvendelse av informasjonen om resistens/ikke-resistens, blandet rånesæd og fremgangsmaoter for utvikling av medikamenter for å kompensere for ikkemotstandsdyktighet mot ETEC.Identification of a pig as resistant or resistant to enterotoxigenic E. coli. In particular, progresses, probes and DNA molecules are generated which include identifying a pig as resistant or non-resistant to ETEC. Progress is also being made to raise pigs using the information on resistance / non-resistance, mixed wafer seed, and proce- dures for the development of drugs to compensate for non-resistance to ETEC.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42873802P | 2002-11-25 | 2002-11-25 | |
DKPA200201819 | 2002-11-25 | ||
PCT/DK2003/000807 WO2004048606A2 (en) | 2002-11-25 | 2003-11-25 | Porcine polymorphisms and methods for detecting them |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20053073D0 NO20053073D0 (en) | 2005-06-23 |
NO20053073L true NO20053073L (en) | 2005-08-25 |
Family
ID=32395324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20053073A NO20053073L (en) | 2002-11-25 | 2005-06-23 | Pig polymorphisms and methods for proving such. |
Country Status (11)
Country | Link |
---|---|
US (1) | US7785778B2 (en) |
EP (1) | EP1565572B1 (en) |
JP (1) | JP2006506991A (en) |
AU (1) | AU2003281988B2 (en) |
CA (1) | CA2507469C (en) |
EA (1) | EA011240B1 (en) |
MX (1) | MXPA05005541A (en) |
NO (1) | NO20053073L (en) |
NZ (1) | NZ540631A (en) |
PL (1) | PL377387A1 (en) |
WO (1) | WO2004048606A2 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050164271A1 (en) * | 2004-01-20 | 2005-07-28 | Sanjay Bhanot | Modulation of glucocorticoid receptor expression |
GB0803076D0 (en) * | 2008-02-20 | 2008-03-26 | Univ Ghent | Mucosal Membrane Receptor and uses thereof |
CN101372712B (en) * | 2008-06-19 | 2010-07-07 | 江西农业大学 | A MUC4 molecular marker and its application to identify susceptibility/resistance to diarrhea in F4 weaned piglets of western pig breeds |
WO2013063313A1 (en) | 2011-10-25 | 2013-05-02 | Isis Pharmaceuticals, Inc. | Antisense modulation of gccr expression |
CA2883566C (en) | 2012-09-03 | 2021-05-18 | Vib Vzw | Protective anti-etec antibody |
FR3042121A1 (en) | 2015-10-08 | 2017-04-14 | Jean-Marc Limacher | ANTI-TUMOR COMPOSITION |
CN105994147A (en) * | 2016-05-30 | 2016-10-12 | 高启忠 | Method for cultivating robust pig specialized strain by means of yulan black pigs |
CN107079874B (en) * | 2017-04-24 | 2020-12-08 | 浙江美保龙种猪育种有限公司 | Breeding method for improving oestrus rate of replacement gilts of American line Bai |
CN107711577A (en) * | 2017-12-01 | 2018-02-23 | 新希望六和股份有限公司 | One broad sow lactation backing plate |
CN109258572A (en) * | 2018-11-21 | 2019-01-25 | 兰坪县建浩农业科技发展有限责任公司 | A kind of drawing horse pig mates method with Duroc |
CN109811061B (en) * | 2019-02-20 | 2023-05-09 | 新疆农业大学 | Detection method and application of COIL gene-specific SNP markers, litter size traits of Hetian Qiaoda red sheep |
KR102438017B1 (en) * | 2020-11-09 | 2022-08-31 | 대한민국 | Method and Kit for Identifying F18 encoding enterotoxigenic and shigatoxin-producing Escherichia coli in Pigs using PNA probe |
CN112266968B (en) * | 2020-11-30 | 2022-06-24 | 华南农业大学 | A molecular marker of copy number variation on chromosome 13 affecting market weight, age and daily gain and its application |
KR102520374B1 (en) * | 2020-12-07 | 2023-04-20 | 대한민국 | Method and Kit for Identifying the serotype of Actinobacillus pleuropneumoniae causing pneumonia in Pigs using PNA probe |
WO2023201950A1 (en) * | 2022-04-22 | 2023-10-26 | 中国农业大学 | Snp molecular marker combination for beijing black pig genotyping, chip, and preparation method therefor and use thereof |
CN115850405B (en) * | 2022-12-12 | 2024-02-02 | 中国动物卫生与流行病学中心 | Antigen fusion protein and application thereof in preparation of vaccine |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4136167A (en) * | 1975-06-12 | 1979-01-23 | Internationale Octrooi Maatschappij "Octropa" B.V. | Process for reducing the incidence of neonatal diarrhoea in pigs |
US4761372A (en) | 1981-01-12 | 1988-08-02 | New York University | Mutant enterotoxin of E. coli |
WO1982003088A1 (en) | 1981-03-09 | 1982-09-16 | Corp Cetus | Vaccines |
US4443549A (en) | 1981-10-19 | 1984-04-17 | Molecular Genetics, Inc. | Production of monoclonal antibodies against bacterial adhesins |
NZ205392A (en) | 1982-09-02 | 1987-03-06 | Unilever Plc | Preparation of immunoglobulins against e.coli pili |
DK41885A (en) | 1985-01-31 | 1986-11-13 | Slagteriernes Forskningsinst | 987P-FIMBRIE-PRODUCING MICROORGANISM, VACCINE FOR IMMUNIZATION OF PIGS, AND PROCEDURE FOR PREPARING THE VACCINE |
US6582908B2 (en) * | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
AU5715194A (en) | 1992-12-04 | 1994-07-04 | N.V. Innogenetics S.A. | New polypeptides, nucleic acid sequences encoding them, and their use to prevent the adhesion of f107-fimbriated bacteria |
US6355859B1 (en) * | 1997-05-20 | 2002-03-12 | Biotechnology Research And Development Corporation | Interactions between genotype and diet in swine that prevent E. coli associated intestinal disease |
CA2290768C (en) | 1997-05-20 | 2008-01-15 | Biotechnology Research And Development Corporation | Methods and compositions to identify swine genetically resistant to f18 e. coli associated diseases |
HU221664B1 (en) | 1999-03-31 | 2002-12-28 | MTA Állatorvostudományi Kutatóintézete | Strain suitable for preparing live oral escherichia coli vaccine for preventing postweaning diarrhoea of pigs, and method for producing that strain |
NZ518319A (en) | 1999-10-22 | 2004-04-30 | Univ Nebraska | Nucleic acid molecules encoding serum amyloid A isoforms from mammalian colostrum used to treat and prevent enteric infections |
JP4771576B2 (en) | 2000-06-12 | 2011-09-14 | 譲治 稲澤 | GASC1 gene |
US20040097440A1 (en) | 2002-11-11 | 2004-05-20 | Isis Pharmaceuticals Inc. | Modulation of jumonji expression |
WO2007053480A2 (en) | 2005-10-28 | 2007-05-10 | The University Of North Carolina At Chapel Hill | Protein demethylases comprising a jmjc domain |
-
2003
- 2003-11-25 AU AU2003281988A patent/AU2003281988B2/en not_active Ceased
- 2003-11-25 CA CA2507469A patent/CA2507469C/en not_active Expired - Lifetime
- 2003-11-25 EA EA200500851A patent/EA011240B1/en not_active IP Right Cessation
- 2003-11-25 PL PL377387A patent/PL377387A1/en not_active Application Discontinuation
- 2003-11-25 US US10/536,184 patent/US7785778B2/en active Active
- 2003-11-25 JP JP2004554245A patent/JP2006506991A/en active Pending
- 2003-11-25 MX MXPA05005541A patent/MXPA05005541A/en unknown
- 2003-11-25 WO PCT/DK2003/000807 patent/WO2004048606A2/en active Application Filing
- 2003-11-25 NZ NZ540631A patent/NZ540631A/en unknown
- 2003-11-25 EP EP03773594A patent/EP1565572B1/en not_active Expired - Lifetime
-
2005
- 2005-06-23 NO NO20053073A patent/NO20053073L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MXPA05005541A (en) | 2006-02-13 |
EP1565572B1 (en) | 2011-05-11 |
NO20053073D0 (en) | 2005-06-23 |
PL377387A1 (en) | 2006-02-06 |
EP1565572A2 (en) | 2005-08-24 |
NZ540631A (en) | 2006-12-22 |
JP2006506991A (en) | 2006-03-02 |
CA2507469C (en) | 2015-04-28 |
WO2004048606A3 (en) | 2004-07-15 |
AU2003281988B2 (en) | 2008-06-12 |
AU2003281988A1 (en) | 2004-06-18 |
US7785778B2 (en) | 2010-08-31 |
CA2507469A1 (en) | 2004-06-10 |
US20060275763A1 (en) | 2006-12-07 |
EA200500851A1 (en) | 2006-02-24 |
EA011240B1 (en) | 2009-02-27 |
WO2004048606A2 (en) | 2004-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20053073L (en) | Pig polymorphisms and methods for proving such. | |
EP1295941A4 (en) | NOVEL NUCLEIC ACID PROBES AND NUCLEIC ACID TEST PROCEDURES USING THE M MES | |
BR0214683A (en) | Nucleotide or nucleoside molecule, methods of labeling a nucleic acid molecule and for determining the sequence of a single stranded target polynucleotide; | |
ATE534748T1 (en) | DIRECT SNP DETECTION USING NON-AMPLIFIED DNA | |
ATE481503T1 (en) | METHOD FOR GENOTYPING ANTIGENS OF BLOOD CELLS AND A KIT FOR GENOTYPING | |
WO2020232635A1 (en) | Method and system for constructing sequencing library on the basis of methylated dna target region, and use thereof | |
ATE377091T1 (en) | METHOD FOR DETECTING NUCLEIC ACIDS | |
DE602004031022D1 (en) | NUCLEIC SEQUENCE IDENTIFICATION | |
Byzia et al. | Recurrent transcriptional loss of the PCDH17 tumor suppressor in laryngeal squamous cell carcinoma is partially mediated by aberrant promoter DNA methylation | |
WO2004044164A3 (en) | Method for identifying risk of melanoma and treatments thereof | |
WO2005027710A3 (en) | Methods for identifying subjects at risk of melanoma and treatments thereof | |
WO2004018647A3 (en) | Methods and compositions for categorizing patients | |
Vidal et al. | Factor IX gene sequencing by a simple and sensitive 15‐hour procedure for haemophilia B diagnosis: identification of two novel mutations | |
Holland | Molecular analysis of the human mitochondrial DNA control region for forensic identity testing | |
AU2020204339B2 (en) | Major histocompatibility complex single nucleotide polymorphisms | |
WO2002016605A1 (en) | Method of protecting personal information | |
ES2308852T3 (en) | GENOMIC AND COMPLETE SEQUENCES OF CDNA OF HUMAN APM1 SPECIFIC FOR ADIPOCITOS AND BIALELIC MARKERS OF THE SAME. | |
Sheng et al. | Active site labeling of HIV-1 reverse transcriptase | |
Guo et al. | Development of SSR primers using ISSR–PCR in Diospyros kaki Thunb. | |
WO2004042345A3 (en) | Bacterial small-molecule three-hybrid system | |
ATE315104T1 (en) | GLAUCOMA DIAGNOSIS AND TREATMENT | |
Cherel et al. | Tetranucleotide microsatellites contribute to a highly discriminating parentage test panel in pig | |
EP1264899A3 (en) | Methods and kits for preparing and detecting RNA probes | |
NO953251D0 (en) | Nucleic acid probes chemically modified in the 5 '(OH) and / or 3' (OH) positions in light of introducing in one or more non-radioactive markings and their preparation | |
DE60334408D1 (en) | NSÄUREN |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |